BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34590434)

  • 21. Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase.
    Xing R; Zhang H; Yuan J; Zhang K; Li L; Guo H; Zhao L; Zhang C; Li S; Gao T; Liu Y; Wang L
    Eur J Med Chem; 2017 Oct; 139():531-541. PubMed ID: 28830032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents.
    Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Baek D; Choi J; Lee H; Oh CH
    J Enzyme Inhib Med Chem; 2016; 31(sup2):111-122. PubMed ID: 27255180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity.
    Adly ME; Gedawy EM; El-Malah AA; El-Telbany FA
    Anticancer Agents Med Chem; 2018; 18(5):747-756. PubMed ID: 29366427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focused library development of 2-phenylacrylamides as broad spectrum cytotoxic agents.
    Tarleton M; Dyson L; Gilbert J; Sakoff JA; McCluskey A
    Bioorg Med Chem; 2013 Jan; 21(1):333-47. PubMed ID: 23176751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
    Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A facile hybrid 'flow and batch' access to substituted 3,4-dihydro-2H-benzo[b][1,4]oxazinones.
    Lin AJ; Russell CC; Baker JR; Frailey SL; Sakoff JA; McCluskey A
    Org Biomol Chem; 2016 Sep; 14(37):8732-8742. PubMed ID: 27714138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of novel benzo[4,5]thiazolo[1,2-a]pyrimidine-3-carboxylate derivatives and biological evaluation as potential anticancer agents.
    Nagarapu L; Vanaparthi S; Bantu R; Ganesh Kumar C
    Eur J Med Chem; 2013 Nov; 69():817-22. PubMed ID: 24113366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents.
    Sabbah DA; Hishmah B; Sweidan K; Bardaweel S; AlDamen M; Zhong HA; Abu Khalaf R; Hasan Ibrahim A; Al-Qirim T; Abu Sheikha G; Mubarak MS
    Anticancer Agents Med Chem; 2018; 18(2):263-276. PubMed ID: 28901259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies.
    Toolabi M; Moghimi S; Bakhshaiesh TO; Salarinejad S; Aghcheli A; Hasanvand Z; Nazeri E; Khalaj A; Esmaeili R; Foroumadi A
    Eur J Med Chem; 2020 Jan; 185():111786. PubMed ID: 31671308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents.
    Farooq S; Hussain A; Qurishi MA; Hamid A; Koul S
    Anticancer Agents Med Chem; 2018; 18(11):1531-1539. PubMed ID: 29298653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and in vitro antiproliferative activity of C5-benzyl substituted 2-amino-pyrrolo[2,3-d]pyrimidines as potent Hsp90 inhibitors.
    Lee JH; Shin SC; Seo SH; Seo YH; Jeong N; Kim CW; Kim EE; Keum G
    Bioorg Med Chem Lett; 2017 Jan; 27(2):237-241. PubMed ID: 27914802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and anticancer activity of focused compound libraries from the natural product lead, oroidin.
    Dyson L; Wright AD; Young KA; Sakoff JA; McCluskey A
    Bioorg Med Chem; 2014 Mar; 22(5):1690-9. PubMed ID: 24508308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of novel substituted pyrimidine derivatives bearing a sulfamide group and their in vitro cancer growth inhibition activity.
    Lefebvre CA; Forcellini E; Boutin S; Côté MF; C-Gaudreault R; Mathieu P; Lagüe P; Paquin JF
    Bioorg Med Chem Lett; 2017 Jan; 27(2):299-302. PubMed ID: 27903409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and antitumor evaluation of novel 5-methylpyrazolo[1,5-a]pyrimidine derivatives as potential c-Met inhibitors.
    Luo G; Ma Y; Liang X; Xie G; Luo Y; Zha D; Wang S; Yu L; Zheng X; Wu W; Zhang C
    Bioorg Chem; 2020 Nov; 104():104356. PubMed ID: 33142417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of new 2,4,6-trisubstituted pyrimidines and their N-alkyl derivatives.
    Kahriman N; Serdaroğlu V; Peker K; Aydın A; Usta A; Fandaklı S; Yaylı N
    Bioorg Chem; 2019 Mar; 83():580-594. PubMed ID: 30471580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [1,2,3]Triazolo[4,5-d]pyrimidine derivatives incorporating (thio)urea moiety as a novel scaffold for LSD1 inhibitors.
    Li ZH; Ma JL; Liu GZ; Zhang XH; Qin TT; Ren WH; Zhao TQ; Chen XH; Zhang ZQ
    Eur J Med Chem; 2020 Feb; 187():111989. PubMed ID: 31881456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel heterocyclic-fused pyrimidine derivatives: synthesis, molecular modeling and pharmacological screening.
    Arafa RK; Nour MS; El-Sayed NA
    Eur J Med Chem; 2013 Nov; 69():498-507. PubMed ID: 24090920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and molecular modeling study of certain VEGFR-2 inhibitors based on thienopyrimidne scaffold as cancer targeting agents.
    Ghith A; Youssef KM; Ismail NSM; Abouzid KAM
    Bioorg Chem; 2019 Mar; 83():111-128. PubMed ID: 30343204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.